Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets - Hillery, CA; Mancuso, DJ; Evan Sadler, J (Blood, 1998)
et al.